Some studies have reported an enhanced survival for BRCA1 carriers with ovarian cancer compared to sporadic cases [12-14,36,37], but these studies have not taken TP53 status in the tumors in to consideration. This evidence concerns the gene BRCA1 and ovarian carcinoma.